THZ531 is a covalent CDK12 and CDK13 inhibitor with IC50 values of 158 nM and 69 nM, respectively.
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe is a synthetic thrombin receptor agonist peptide.
Lazertinib, also known as YH-25448 and GNS-1480, is an oral active, highly potent, mutant-selective and irreversible EGFR Tyrosine-kinase inhibitors (TKIs) targets both the T790M mutation and activating EGFR mutations while sparing wild type-EGFR.
Lazertinib, also known as YH-25448 and GNS-1480, is an oral active, highly potent, mutant-selective and irreversible EGFR Tyrosine-kinase inhibitors (TKIs) targets both the T790M mutation and activating EGFR mutations while sparing wild type-EGFR.
Uridine 5'-diphosphoglucose disodium salt is an agonist of the P2Y14 receptor, with EC50 of 0.35 μM. Uridine 5′-diphosphoglucose disodium salt (UDP-Glucose sodium salt) can also bind to and activate GPR17, inducing oligodendrocyte differentiation at a maximal concentration of 100 μM.
Uridine 5'-diphosphoglucose disodium salt is an agonist of the P2Y14 receptor, with EC50 of 0.35 μM. Uridine 5′-diphosphoglucose disodium salt (UDP-Glucose sodium salt) can also bind to and activate GPR17, inducing oligodendrocyte differentiation at a maximal concentration of 100 μM.
GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor.
GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor.
CAY10602 is a SIRT1 activator, which suppresses the NF-κB-dependent induction of TNF-α by lipopolysaccharide in THP-1 cells dose-dependently.